DE69431432D1 - Untereinheiten von menschlichen n-methyl-d-aspartat rezeptoren, diese kodierende nukleinsäure und dessen verwendung - Google Patents
Untereinheiten von menschlichen n-methyl-d-aspartat rezeptoren, diese kodierende nukleinsäure und dessen verwendungInfo
- Publication number
- DE69431432D1 DE69431432D1 DE69431432T DE69431432T DE69431432D1 DE 69431432 D1 DE69431432 D1 DE 69431432D1 DE 69431432 T DE69431432 T DE 69431432T DE 69431432 T DE69431432 T DE 69431432T DE 69431432 D1 DE69431432 D1 DE 69431432D1
- Authority
- DE
- Germany
- Prior art keywords
- subunits
- nucleic acids
- human
- receptors
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5244993A | 1993-04-20 | 1993-04-20 | |
PCT/US1994/004387 WO1994024284A1 (en) | 1993-04-20 | 1994-04-20 | Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69431432D1 true DE69431432D1 (de) | 2002-10-31 |
DE69431432T2 DE69431432T2 (de) | 2003-04-24 |
Family
ID=21977682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69431432T Revoked DE69431432T2 (de) | 1993-04-20 | 1994-04-20 | Untereinheiten von menschlichen n-methyl-d-aspartat rezeptoren, diese kodierende nukleinsäure und dessen verwendung |
Country Status (10)
Country | Link |
---|---|
US (11) | US5849895A (de) |
EP (1) | EP0696320B1 (de) |
JP (1) | JPH08509607A (de) |
AT (1) | ATE224952T1 (de) |
AU (1) | AU696922B2 (de) |
CA (1) | CA2159106C (de) |
DE (1) | DE69431432T2 (de) |
ES (1) | ES2182843T3 (de) |
GB (1) | GB2286188B (de) |
WO (1) | WO1994024284A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2110934A1 (en) | 1992-12-11 | 1994-06-12 | Robert L. Foldes | Human cns receptors of the nmda-r1 family |
DE69431432T2 (de) | 1993-04-20 | 2003-04-24 | Merck & Co Inc | Untereinheiten von menschlichen n-methyl-d-aspartat rezeptoren, diese kodierende nukleinsäure und dessen verwendung |
EP0674003A3 (de) * | 1994-03-25 | 1997-09-10 | Allelix Biopharma | Proteine die menschliche CNS Rezeptoren modulieren. |
GB9414997D0 (en) * | 1994-07-26 | 1994-09-14 | Merck Sharp & Dohme | Receptor cloning |
US6362009B1 (en) | 1997-11-21 | 2002-03-26 | Merck & Co., Inc. | Solid phase synthesis of heterocycles |
US6822084B1 (en) * | 1999-06-25 | 2004-11-23 | Basf Aktiengesellschaft | Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
CA2383047A1 (en) * | 1999-08-31 | 2001-03-08 | Trustees Of Boston University | Effect of steroids on nmda receptors depends on subunit composition |
US20040204490A1 (en) * | 1999-08-31 | 2004-10-14 | Farb David H. | Effect of steroids on NMDA receptors depends on subunit composition |
US6916816B2 (en) * | 1999-12-16 | 2005-07-12 | The Board Of Regents Of The University Of Nebraska | Phenanthryl piperazinyl dicarboxylic acids as selective NMDA receptor modulating agents |
GB9929582D0 (en) * | 1999-12-16 | 2000-02-09 | Univ Bristol | Chemical compounds |
US20030092071A1 (en) * | 2000-02-01 | 2003-05-15 | Jasna Jerecic | Interaction of NMDA receptor with protein tyrosine phosphatase |
JP2003521247A (ja) * | 2000-02-01 | 2003-07-15 | エージーワイ セラピューティクス インコーポレーテッド | Nmda受容体のプロテインチロシンホスファターゼとの相互作用 |
WO2002064772A1 (fr) * | 2001-01-30 | 2002-08-22 | Shionogi & Co., Ltd. | Variant d'epissure du recepteur nmda humain |
US6896872B2 (en) * | 2001-06-27 | 2005-05-24 | Svetlana A. Dambinova | Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke |
WO2003010540A1 (en) * | 2001-07-25 | 2003-02-06 | Nyxis Neurotherapies, Inc. | Method of identifying nmda-related agent |
US6638981B2 (en) * | 2001-08-17 | 2003-10-28 | Epicept Corporation | Topical compositions and methods for treating pain |
US6701482B2 (en) * | 2001-09-20 | 2004-03-02 | Qualcomm Incorporated | Method and apparatus for coding bits of data in parallel |
EP2390308A1 (de) | 2002-02-25 | 2011-11-30 | Vaxiion Therapeutics Inc | Minizell-Zusammensetzungen und Verfahren |
US6884473B2 (en) * | 2002-12-24 | 2005-04-26 | Macronix International Co., Ltd. | Method for fabricating metal silicide |
US7354834B2 (en) * | 2003-06-04 | 2008-04-08 | Dongbu Electronics Co., Ltd. | Semiconductor devices and methods to form trenches in semiconductor devices |
US20050202407A1 (en) * | 2003-12-01 | 2005-09-15 | Baylor College Of Medicine | Methods and assays for screening anti-neoplastic therapeutic agents |
US20060257943A1 (en) * | 2005-01-25 | 2006-11-16 | Cis Biotech, Inc. | Ischemic biomarkers and their use to predict adverse neurological events from surgery |
DE602006018145D1 (de) * | 2005-06-13 | 2010-12-23 | Cis Biotech Inc | Verfahren zur diagnose und behandlung auf nr2-peptiden beruhender zerebrovaskulärer ereignisse |
CA2615147A1 (en) * | 2005-07-14 | 2007-01-18 | The University Of British Columbia | Neuroprotective modulation of nmda receptor subtype activities |
EP1902733A1 (de) * | 2006-09-19 | 2008-03-26 | Laboratorios Del Dr. Esteve, S.A. | Kombination von einem NMDA Rezeptorligand und einer Verbindung mit 5-HT6 Rezeptor-Affinität |
WO2008073984A2 (en) * | 2006-12-12 | 2008-06-19 | Cis Biotech, Inc. | Nmdar biomarkers for diagnosing and treating cerebral ischemia |
US20100316678A1 (en) * | 2007-06-28 | 2010-12-16 | Cnsbio Pty Ltd. | Combination methods and compositions for treatment of neuropathic pain |
CA2716080C (en) | 2008-02-20 | 2016-12-13 | Targia Pharmaceuticals | Cns pharmaceutical compositions and methods of use |
CA2738468A1 (en) | 2008-09-27 | 2010-04-01 | Taraxos Inc. | Topical formulations for treatment of neuropathy |
WO2017109709A2 (en) * | 2015-12-22 | 2017-06-29 | Novartis Ag | A high-throughput assay method for identifying allosteric nmda receptor modulators |
RU2668534C1 (ru) * | 2017-07-18 | 2018-10-01 | Общество с ограниченной ответственностью "ДРД" | Диагностический набор реагентов для выявления хронических патологий мозга ишемического генеза |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4837148A (en) * | 1984-10-30 | 1989-06-06 | Phillips Petroleum Company | Autonomous replication sequences for yeast strains of the genus pichia |
US4855231A (en) * | 1984-10-30 | 1989-08-08 | Phillips Petroleum Company | Regulatory region for heterologous gene expression in yeast |
US4882279A (en) * | 1985-10-25 | 1989-11-21 | Phillips Petroleum Company | Site selective genomic modification of yeast of the genus pichia |
US5024939A (en) * | 1987-07-09 | 1991-06-18 | Genentech, Inc. | Transient expression system for producing recombinant protein |
US4929555A (en) * | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
EP0497884B1 (de) * | 1989-10-27 | 2004-04-28 | The Salk Institute For Biological Studies | Rezeptorverbindungen von glutamin und herstellung |
US5028707A (en) * | 1989-11-20 | 1991-07-02 | Board Of Regents, University Of Texas | 4-hydroxyquinaldic acid derivatives |
US5401629A (en) * | 1990-08-07 | 1995-03-28 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Assay methods and compositions useful for measuring the transduction of an intracellular signal |
US5146257A (en) | 1991-02-19 | 1992-09-08 | Minnesota Mining And Manufacturing Company | Developer solution replenishment control system for a digital imaging system |
US5455279A (en) * | 1991-04-19 | 1995-10-03 | The Children's Medical Center Corporation | Regimen method of mediating neuronal damage using nitroglycerine |
US5502168A (en) * | 1991-10-24 | 1996-03-26 | The Johns Hopkins University | Monoclonal antibodies to a continuous and cross-reactive epitope and an isolated protein of a sexual stage of P. falciparum |
US5670113A (en) * | 1991-12-20 | 1997-09-23 | Sibia Neurosciences, Inc. | Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same |
JP3353841B2 (ja) * | 1992-11-13 | 2002-12-03 | 三菱化学株式会社 | 新規なタンパク質およびそれをコードする遺伝子 |
JPH0614783A (ja) * | 1992-06-30 | 1994-01-25 | Mitsubishi Kasei Corp | 新規なタンパク質およびそれをコードする遺伝子 |
JP3400470B2 (ja) * | 1992-08-12 | 2003-04-28 | 三菱化学株式会社 | 新規なタンパク質およびそれをコードする遺伝子 |
US5502166A (en) * | 1992-02-26 | 1996-03-26 | Mitsubishi Chemical Corporation | NMDH receptor proteins and genes encoding the same |
DE4216321A1 (de) * | 1992-05-16 | 1993-11-18 | Basf Ag | Untereinheiten von NMDA-Rezeptoren, Verfahren zu ihrer Herstellung und ihre Verwendung |
DK68592D0 (da) * | 1992-05-25 | 1992-05-25 | Novo Nordisk As | Celle |
FR2692268B1 (fr) | 1992-06-15 | 1994-08-19 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides ayant une activité de récepteur NMDA, acides nucléiques codant pour ces polypeptides et utilisations. |
DE4222826A1 (de) * | 1992-07-09 | 1994-01-13 | Schering Ag | Arzneimittel zur Verhinderung der Toleranzentwicklung während der Behandlung mit Benzodiazepin-Rezeptor-Bindenen Wirkstoffen |
DE4227657A1 (de) | 1992-08-21 | 1994-02-24 | Hydac Technology Gmbh | Ultraschall-Prüfeinrichtung für Gasdruckspeicher |
AU5429794A (en) * | 1992-11-12 | 1994-06-08 | Merck Sharp & Dohme Limited | Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them |
GB9307026D0 (en) | 1993-04-02 | 1993-05-26 | Merck Sharp & Dohme | Receptor cloning |
GB9223769D0 (en) | 1992-11-12 | 1992-12-23 | Merck Sharp & Dohme | Receptor cloning |
CA2110934A1 (en) * | 1992-12-11 | 1994-06-12 | Robert L. Foldes | Human cns receptors of the nmda-r1 family |
DE69431432T2 (de) * | 1993-04-20 | 2003-04-24 | Merck & Co Inc | Untereinheiten von menschlichen n-methyl-d-aspartat rezeptoren, diese kodierende nukleinsäure und dessen verwendung |
US5364590A (en) | 1993-05-07 | 1994-11-15 | American Sterlizer Company | Method for sterilization of objects |
EP0674003A3 (de) * | 1994-03-25 | 1997-09-10 | Allelix Biopharma | Proteine die menschliche CNS Rezeptoren modulieren. |
DE4410882A1 (de) * | 1994-03-29 | 1995-10-05 | Basf Ag | Verfahren zur permanenten Expression von Glutamatrezeptoren |
GB9414997D0 (en) * | 1994-07-26 | 1994-09-14 | Merck Sharp & Dohme | Receptor cloning |
-
1994
- 1994-04-20 DE DE69431432T patent/DE69431432T2/de not_active Revoked
- 1994-04-20 EP EP94916547A patent/EP0696320B1/de not_active Revoked
- 1994-04-20 GB GB9503689A patent/GB2286188B/en not_active Expired - Fee Related
- 1994-04-20 AT AT94916547T patent/ATE224952T1/de not_active IP Right Cessation
- 1994-04-20 US US08/231,193 patent/US5849895A/en not_active Expired - Fee Related
- 1994-04-20 AU AU68175/94A patent/AU696922B2/en not_active Ceased
- 1994-04-20 CA CA002159106A patent/CA2159106C/en not_active Expired - Fee Related
- 1994-04-20 ES ES94916547T patent/ES2182843T3/es not_active Expired - Lifetime
- 1994-04-20 WO PCT/US1994/004387 patent/WO1994024284A1/en not_active Application Discontinuation
- 1994-04-20 JP JP6523578A patent/JPH08509607A/ja active Pending
-
1995
- 1995-06-06 US US08/486,273 patent/US5985586A/en not_active Expired - Fee Related
- 1995-06-06 US US08/480,474 patent/US6033865A/en not_active Expired - Fee Related
-
1997
- 1997-09-29 US US08/940,086 patent/US6111091A/en not_active Expired - Fee Related
- 1997-09-29 US US08/940,035 patent/US6316611B1/en not_active Expired - Fee Related
- 1997-09-29 US US08/935,105 patent/US6376660B1/en not_active Expired - Fee Related
-
1999
- 1999-08-30 US US09/386,123 patent/US6521413B1/en not_active Expired - Fee Related
-
2000
- 2000-08-28 US US09/648,797 patent/US6469142B1/en not_active Expired - Fee Related
-
2001
- 2001-09-04 US US09/945,901 patent/US6956102B2/en not_active Expired - Fee Related
- 2001-12-07 US US10/007,747 patent/US6864358B2/en not_active Expired - Fee Related
-
2002
- 2002-01-04 US US10/038,937 patent/US6825322B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6825322B2 (en) | 2004-11-30 |
ES2182843T3 (es) | 2003-03-16 |
US6111091A (en) | 2000-08-29 |
US6956102B2 (en) | 2005-10-18 |
US5849895A (en) | 1998-12-15 |
CA2159106A1 (en) | 1994-10-27 |
DE69431432T2 (de) | 2003-04-24 |
AU696922B2 (en) | 1998-09-24 |
US6521413B1 (en) | 2003-02-18 |
US20030013866A1 (en) | 2003-01-16 |
US6316611B1 (en) | 2001-11-13 |
US20020161193A1 (en) | 2002-10-31 |
ATE224952T1 (de) | 2002-10-15 |
AU6817594A (en) | 1994-11-08 |
GB2286188B (en) | 1997-11-12 |
US20020161215A1 (en) | 2002-10-31 |
US5985586A (en) | 1999-11-16 |
US6376660B1 (en) | 2002-04-23 |
US6469142B1 (en) | 2002-10-22 |
GB2286188A (en) | 1995-08-09 |
EP0696320B1 (de) | 2002-09-25 |
JPH08509607A (ja) | 1996-10-15 |
CA2159106C (en) | 2009-10-06 |
GB9503689D0 (en) | 1995-04-12 |
US6033865A (en) | 2000-03-07 |
US6864358B2 (en) | 2005-03-08 |
WO1994024284A1 (en) | 1994-10-27 |
EP0696320A1 (de) | 1996-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69431432D1 (de) | Untereinheiten von menschlichen n-methyl-d-aspartat rezeptoren, diese kodierende nukleinsäure und dessen verwendung | |
DK1012274T3 (da) | Dödsdomæneholdig receptor-4 (DR4: dödsreceptor 4), medlem af TNF-receptorsuperfamilien og som binder til TRAIL (Apo-2L) | |
NO20010320L (no) | Nukleinsyrer som koder for en G-proteinkoblet reseptor som er involvert i sensorisk transduksjon | |
DE69435268D1 (de) | Menschliche metabotropische rezeptoren, diese kodierende nukleinsäure und ihre verwendung | |
Atanasova et al. | Understanding cytokine and growth factor receptor activation mechanisms | |
DE69535641D1 (de) | Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen | |
Wang et al. | Amino acids of the human growth hormone receptor that are required for proliferation and Jak-STAT signaling. | |
ATE365796T1 (de) | Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta | |
BR9708518A (pt) | Moduladores de fator associado a receptor tnf (traf) sua preparação e uso | |
DK1229047T3 (da) | IL-1-receptor-fusionsproteiner anvendt som antagonister og fremgangsmåder til fremstilling og anvendelse | |
WO1998031806A3 (en) | Fc receptors and polypeptides | |
ATE490323T1 (de) | Adiponektin-rezeptor und dafür kodierendes gen | |
ATE335818T1 (de) | Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung | |
DE69732631D1 (de) | Metabotropische gaba(b) rezeptoren, rezeptoren-spezifische liganden und deren anwendungen | |
Miles et al. | Allosteric activation of the 5-HT3AB receptor by mCPBG | |
ATE462721T1 (de) | Breit einsetzbares verfahren zur identifizierung von modulatoren von g-protein gekoppelten rezeptoren | |
DE60233728D1 (de) | Kationenleitende gaba-a-rezeptoren und deren verwendung | |
WO2003087331A3 (en) | Polyvalent cation-sensing receptor in atlantic salmon | |
DK1408109T3 (da) | Hidtil ukendt fremgangsmåde til induktion af cellesenescens og fremgangsmåde til screening for et antiældningsmiddel | |
WO2002057421A3 (en) | Human tumor necrosis factor receptors tr13 and tr14 | |
EP1712631A3 (de) | Fc Rezeptoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8339 | Ceased/non-payment of the annual fee | ||
8331 | Complete revocation | ||
8380 | Miscellaneous part iii |
Free format text: DIE ZURUECKNAHME VOM 14.02.2008 WURDE GELOESCHT. |